Health-related quality of life after treatment for bladder cancer in England

Samantha J. Mason, Amy Downing, Penny Wright, Luke Hounsome, Sarah E. Bottomley, Jessica Corner, Mike Richards, James W. Catto, Adam W. Glaser

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

Background: Little is known about quality of life after bladder cancer treatment. This common cancer is managed using treatments that can affect urinary, sexual and bowel function. Methods: To understand quality of life and inform future care, the Department of Health (England) surveyed adults surviving bladder cancer 1-5 years after diagnosis. Questions related to disease status, co-existing conditions, generic health (EQ-5D), cancer-generic (Social Difficulties Inventory) and cancer-specific outcomes (Functional Assessment of Cancer Therapy - Bladder). Results: In total, 673 (54%) patients responded; including 500 (74%) men and 539 (80%) with co-existing conditions. Most respondents received endoscopic treatment (60%), while 92 (14%) and 99 (15%) received radical cystectomy or radiotherapy, respectively. Questionnaire completion rates varied (51-97%). Treatment groups reported ≥1 problem using EQ-5D generic domains (59-74%). Usual activities was the most common concern. Urinary frequency was common after endoscopy (34-37%) and radiotherapy (44-50%). Certain populations were more likely to report generic, cancer-generic and cancer-specific problems; notably those with co-existing long-term conditions and those treated with radiotherapy. Conclusion: The study demonstrates the importance of assessing patient-reported outcomes in this population. There is a need for larger, more in-depth studies to fully understand the challenges patients with bladder cancer face.

Original languageEnglish
Pages (from-to)1518-1528
Number of pages11
JournalBritish Journal of Cancer
Volume118
Issue number11
DOIs
Publication statusPublished - 1 May 2018

Fingerprint

Dive into the research topics of 'Health-related quality of life after treatment for bladder cancer in England'. Together they form a unique fingerprint.

Cite this